HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Naoki Isogawa Selected Research
Naoki Isogawa Research Topics
Disease
3
Ulcerative Colitis
10/2019 - 01/2018
2
Pain (Aches)
09/2022 - 01/2021
2
Osteoarthritis
09/2022 - 01/2021
2
Herpes Zoster
10/2019 - 11/2017
1
Coronary Artery Disease (Coronary Atherosclerosis)
11/2022
1
Diabetes Mellitus
11/2022
1
Heart Failure
11/2022
1
Hypertension (High Blood Pressure)
11/2022
1
Neoplasms (Cancer)
11/2022
1
Osteonecrosis (Kienbock's Disease)
09/2022
1
Low Back Pain (Lumbago)
04/2022
1
Arthralgia (Joint Pain)
01/2021
1
Hip Osteoarthritis (Coxarthrosis)
01/2021
1
Crohn Disease (Crohn's Disease)
01/2020
1
Ulcer
01/2020
1
Infections
04/2018
1
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2017
1
Macular Edema
09/2014
Drug/Important Bio-Agent (IBA)
4
tofacitinib
IBA
10/2019 - 11/2017
3
tanezumab
IBA
09/2022 - 01/2021
2
Monoclonal Antibodies
IBA
09/2022 - 01/2020
2
Prostaglandins A
IBA
09/2022 - 11/2017
2
Janus Kinase Inhibitors
IBA
10/2019 - 04/2018
1
Immunologic Factors (Immunomodulators)
IBA
11/2022
1
HDL Lipoproteins
IBA
11/2022
1
Nerve Growth Factor (NGF)
IBA
09/2022
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
09/2022
1
Celecoxib (Celebrex)
FDA Link
04/2022
1
Analgesics (Analgesic Drugs)
IBA
01/2021
1
ontamalimab
IBA
01/2020
1
Cell Adhesion Molecule-1
IBA
01/2020
1
C-Reactive Protein
IBA
01/2020
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2020
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020
1
pegaptanib (Macugen)
FDA Link
09/2014
Therapy/Procedure
3
Therapeutics
10/2019 - 01/2018
1
Intravitreal Injections
09/2014